Substantial problems concerning obesity and T1DM include difficulty in distinguishing the types of disease in adolescents with features of insulin resistance, weight gain during intensive insulin therapy, the potential impact of obesity on long-term complications, and the relationship of body weight with metabolic control. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.